Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Autonomize AI

Explore full profile

AI-powered agents and copilots for healthcare workflows

Austin, United StatesFounded 2021Health Tech & Medtech
Valuation $100–250M Last recorded · 2025
Revenue <$1M Latest reported FY
Headcount 100–500 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Autonomize AI and the history behind them.

About Autonomize AI

Autonomize AI is a technology company founded in 2021 by Ganesh Padmanabhan and Kris Nair and is headquartered in Austin, Texas. The firm develops an artificial intelligence orchestration platform with pre-trained AI agents that function as intelligent copilots for healthcare and life sciences organizations. This platform is designed to organize, contextualize, and summarize unstructured healthcare data, assisting knowledge workers in making data-driven decisions.

The company's mission was influenced by co-founder and CEO Ganesh Padmanabhan's experience during the COVID-19 pandemic, which highlighted the fragility of the healthcare system. Padmanabhan, who has a background in mechanical engineering and previously worked at Dell Technologies and Intel, sought to apply his expertise in data and AI to address significant challenges in the medical industry. Before founding Autonomize, he engaged in extensive research, consulting with healthcare companies to identify critical problems. Co-founder and CTO Kris Nair shared the vision of creating a platform built for the complexity and regulatory environment of healthcare.

Autonomize AI's business model is centered on providing its platform to clients such as health plans, providers, and life sciences companies, including Fortune 100 healthcare enterprises and Top 20 pharmaceutical firms. The platform addresses demanding administrative workflows like care management, utilization management, prior authorizations, and chart reviews. By automating these tasks, the company aims to reduce administrative burdens, lower costs, and allow clinicians to focus on patient care. Its products include solutions for accelerating clinical trials and augmenting clinical decisions with insights from medical charts. The company has secured significant venture capital, raising a $4 million seed round in 2023 and a $28 million Series A round in 2025, bringing its total funding to $32 million. These funds are allocated to research and development, commercialization efforts, and scaling deployments across the healthcare sector.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2021
Headquarters
Austin, United States
Employees
128
Open positions
14
Dealroom signal
92.9/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Medical Data Systems, Core AI, Physician Support Tools, Hard Tech, AI Applications, AI Agents
Technology
Artificial Intelligence
Business model
SaaS
Client focus
b2b

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Jun 2025 $28M $112M ATX Venture Partners · Valtruis · Capital Factory · Tau Ventures ↗
EARLY VC✓Equity / VC Apr 2023 $4M $16M Undisclosed ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Autonomize AI website traffic

Latest recorded traffic for Autonomize AI is 18K monthly website visits, up 38.5% over the last three months. Autonomize AI's team grew 23.1% over the past year.

Latest monthly visits18K 3-month web change+38.5% 1-year team growth+23.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • Valtruis
  • Tau Ventures
  • Cigna Ventures
  • ATX Venture Partners
  • Capital Factory
  • Asset Management Ventures

Other known investors1 additional known investor

  • Nvidia Inception
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
6 countries with
team presence
🇮🇳 India48.1%
🇺🇸 United States44.4%
🇨🇦 Canada2.8%
🇧🇷 Brazil0.9%
🇦🇪 United Arab Emirates0.9%
Top 5 of 6 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Autonomize AI on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Autonomize AI’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.